UK 109,496,
UK 109496,
UK-109,496,
UK-109496,
UK109,496,
UK109496,
Vfend,
voriconazole,
Voriconazole,
137234-62-9,
Vfend,
UK-109496,
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
Voriconazol,
UK 109496,
Voriconazolum,
Voriconazole [USAN:INN:BAN],
UNII-JFU09I87TR,
DRG-0301,
UK-109,496,
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol,
VCZ,
CHEMBL638,
JFU09I87TR,
CPD000466350,
C16H14F3N5O,
CHEBI:10023,
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol,
(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol,
VRC,
DSSTox_CID_26485,
DSSTox_RID_81656,
DSSTox_GSID_46485,
2R,3S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-,
4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))-,
Vorikonazole,
(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-((1H)-1,2,4-triazol-1-yl)-butan-2-ol,
SMR000466350,
CAS-137234-62-9,
Vfend (TN),
Voriconazole related compound A,
VFEND I.V.,
Pfizer,
MFCD00905717,
NCGC00164622-01,
Voriconazole, 98%,
Voriconazole - Vfend,
(+/-)-Voriconazole,
Voriconazole in combination with MGCD290,
AC1L2GHR,
Voriconazole, (+/-)-,
AC1Q4O6I,
SCHEMBL36233,
MLS000759464,
MLS001424082,
MLS006010028,
DTXSID5046485,
CTK8E9205,
ZINC14864,
SYN3012,
Voriconazole (JP17/USAN/INN),
Voriconazole, >=98% (HPLC),
BCEHBSKCWLPMDN-MGPLVRAMSA-N,
BCPP000019,
HMS2051N09,
HMS3260M22,
HMS3713F12,
Pharmakon1600-01502346,
Tox21_112241,
Tox21_500150,
Voriconazole 2.0 mg/ml in Methanol,
AC-823,
BDBM50333117,
MFCD20488064,
NSC759888,
s1442,
AKOS005145705,
Tox21_112241_1,
CCG-100941,
CS-1227,
DB00582,
KS-1157,
NC00191,
NSC-759888,
SB17419,
KS-0000001W,
NCGC00164622-02,
NCGC00164622-04,
NCGC00260835-01,
(alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol,
AN-15471,
BC660191,
HY-76200,
I992,
SAM001246664,
SC-25806,
Voriconazole related compound A RS [USP],
AB0013963,
LS-181799,
RT-016239,
TL8000858,
FT-0082604,
FT-0631154,
SW197571-2,
C07622,
D00578,
J10329,
W-5208,
AB00639948-04,
AB00639948-06,
AB00639948_07,
AB00639948_08,
Voriconazole, VETRANAL(TM), analytical standard,
234V629,
J-006986,
Z2616414875,
UNII-USG4B1CD29 component BCEHBSKCWLPMDN-MGPLVRAMSA-N,
Voriconazole, European Pharmacopoeia (EP) Reference Standard,
Voriconazole, United States Pharmacopeia (USP) Reference Standard,
(2R,3S)-2,3-bis(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
Voriconazole, Pharmaceutical Secondary Standard: Certified Reference Material,
(2R,3S)-2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol,
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol,
(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol,
(2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol,
4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-rel-,
V-fend,
Vfend, Voriconazole,
Pfizer brand of voriconazole,
D0N3VR,
UNII-USG4B1CD29,
USG4B1CD29,
Voriconazole (JAN/USAN/INN),
Voriconazole [USAN:BAN:INN],
CID71616,
C16-H14-F3-N5-O,
UK109496,
ACN-036096,
CB11360,
CS-O-02561,
UK 109,496,
UK109,496,
A4320,
V0116,
A10978,
C102790,
D065819,
188416-29-7,
VOR,
Voriconazole, 98%, a potent and broad-spectrum anti-fungal agent - 1G 1g,
(2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
(alpha R,beta S)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimideethanol,
136285-65-9,
173967-54-9,